Artificial oocyte activation may improve embryo quality in older patients with diminished ovarian reserve undergoing IVF-ICSI cycles

• Hauptverfasser: Tzung-En Tsai (Verfasst von), Pei-Hsuan Lin (Verfasst von), Pei-Fen Lian (Verfasst von), Chia-Jung Li (Verfasst von), Salvatore Giovanni Vitale (Verfasst von), Mislav Mikuš (Verfasst von), Wan-Ping Su (Verfasst von), Hsiao-Wen Tsai (Verfasst von), Kuan-Hao Tsui (Verfasst von), Li-Te Lin (Verfasst von)
• Format: Buch
• Veröffentlicht: BMC, 2022-09-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Abstract Background Artificial oocyte activation (AOA) is used to improve fertilization rate following fertilization failure after intracytoplasmic sperm injection (ICSI). Several studies have also shown that AOA may be involved in embryo development. Women with poor ovarian response are more likely...